Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 80

Sort by

Sort Order Select

Journal Articles

Validation and Retraining of the Stellae-123 Gene Expression Signature Improved Risk Stratification in Taiwanese Acute Myeloid Leukemia Patients

Yu-Hung Wang, Adrian Mosquera Orgueira, Chien-Chin Lin, Chi-Yuan Yao, Min Yen Lo, Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien

Blood (2023) 142 (Supplement 1): 1472.

https://doi.org/10.1182/blood-2023-179847

Published: 2023

Journal Articles

Genomic Characterization of Acute Myeloid Leukemia with Aberrations of Chromosome 7: A Multinational Cohort of 523 Patients

Blood (2023) 142 (Supplement 1): 63.

https://doi.org/10.1182/blood-2023-185627

Published: 2023

Journal Articles

FLT3 Testing and Clonal Evolution in Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study in Taiwan

Xavier Cheng-Hong Tsai, Hwei-Fang Tien, Wen-Chien Chou, Prabhuram Krishnan, Yu-Yao Tai, Hsin-An Hou

Blood (2023) 142 (Supplement 1): 7422.

https://doi.org/10.1182/blood-2023-180617

Published: 2023

Journal Articles

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Harinder Gill, Hsin An Hou, Paul Lee, Rita Yim, Xavier Cheng-Hong Tsai, Melissa Ooi, Tsz-Shing Hui, Radha Raghupathy, Lynn Chin, Lester Au, Vivian Li, Garret Man Kit Leung, Edmond Ma, Asif Javed, Ho-Wan Ip, Wee-Joo Chng, Wen-Chien Chou, Hwei-Fang Tien, Yok-Lam Kwong

Blood (2023) 142 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2023-182750

Published: 2023

Journal Articles

Prognostic and Therapeutic Implications of TP53 expression in Chronic Myelomonocytic Leukaemia: Results of a Multicentre Study

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Fabio Amaral, Chi-Yuan Yao, Joanna Storer, Luciano Nicosia, Bettina Wingelhofer, Hsin-An Hou, Andres Jerez, Wen-Chien Chou, Kiran Batta, Hwei-Fang Tien, Daniel H Wiseman

Blood (2023) 142 (Supplement 1): 3213.

https://doi.org/10.1182/blood-2023-180034

Published: 2023

Journal Articles

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien

Blood (2023) 142 (Supplement 1): 627.

https://doi.org/10.1182/blood-2023-179907

Published: 2023

Journal Articles

Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification

Hsin-Yu Lu, Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hsin-An Hou, Hwei-Fang Tien, Wen-Chien Chou

Blood (2023) 142 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2023-186106

Published: 2023

Journal Articles

A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia

Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Kristian Gurashi, Fabio Amaral, Andres Jerez, Tim C.P Somervaille, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Hwei-Fang Tien, Daniel H Wiseman

Blood (2022) 140 (Supplement 1): 1104–1105.

https://doi.org/10.1182/blood-2022-165449

Published: 2022

Journal Articles

Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation

Min Yen Lo, Cheng-Hong Tsai, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Cheng-An Hsu, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2022) 140 (Supplement 1): 130–131.

https://doi.org/10.1182/blood-2022-168522

Published: 2022

Journal Articles

Effect of Mutation Allele Frequency on the Risk Stratification of Myelodysplastic Syndrome Patients

Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2022) 140 (Supplement 1): 6932–6933.

https://doi.org/10.1182/blood-2022-159872

Published: 2022

Journal Articles

Conditional Knock-out of Phf6 Decreases CD44 Expression on Naïve CD4 + T Cells and Skews the Differentiation Toward Regulatory T Cells in Mice

Tsung-Chih Chen, Chia-Lang Hsu, Chi-Yuan Yao, Yu-Ren Chen, Yueh-Chwen Hsu, Chein-Jun Kao, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien

Blood (2022) 140 (Supplement 1): 2635–2636.

https://doi.org/10.1182/blood-2022-155984

Published: 2022

Journal Articles

Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma

Yu-Hua Fu, Shang-Ju Wu, Elise Chia-Hui Tan, Chi-Chuan Wang, Kibum Kim, Wen-Chien Chou, Fang-Ju Lin

Blood (2022) 140 (Supplement 1): 10808–10809.

https://doi.org/10.1182/blood-2022-162980

Published: 2022

Journal Articles

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3 mut+ AML ineligible for intensive chemotherapy

Blood (2022) 140 (17): 1845–1857.

https://doi.org/10.1182/blood.2021014586

Published: 2022

Includes: Supplemental data

Journal Articles

Phase 3, Open-Label, Randomized Study of Gilteritinib and Azacitidine Vs Azacitidine for Newly Diagnosed FLT3 -Mutated Acute Myeloid Leukemia in Patients Ineligible for Intensive Induction Chemotherapy

Blood (2021) 138 (Supplement 1): 700.

https://doi.org/10.1182/blood-2021-145379

Published: 2021

Journal Articles

RUNX1 Expression Can be Complementary to RUNX1 Mutation in MDS Prognostication

Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Chia-Lang Hsu, Hsin-An Hou, Hwei-Fang Tien, Wen-Chien Chou

Blood (2021) 138 (Supplement 1): 2614.

https://doi.org/10.1182/blood-2021-145422

Published: 2021

Journal Articles

Metabolic Profiling Reveals Cellular Reprogramming of Acute Myeloid Leukemia By Omipalisib through Serine Synthesis Pathway

Liang-In Lin, Tseng Chiyang, Yu-Hsuan Fu, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien

Blood (2021) 138 (Supplement 1): 3296.

https://doi.org/10.1182/blood-2021-149200

Published: 2021

Journal Articles

Epidemiology of Light-Chain Amyloidosis: A Population-Based Cohort Study in Taiwan

Hsin-An Hou, Chao-Hsiun Tang, Choo Hua Goh, Sarah Siggins, Shih-Pei Shen, Hong Qiu, Wen-Chien Chou, Yanfang Liu

Blood (2021) 138 (Supplement 1): 1637.

https://doi.org/10.1182/blood-2021-147660

Published: 2021

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

Journal Articles

Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma

Cheng-Hong Tsai, MD MSc, Feng Ming Tien, MD MSc, Hsin-An Hou, MD PhD, Jia-Hau Liu, MD, Shang-Ju Wu, MD PhD, Yu-Wen Wang, MSc., Chien-Chin Lin, MD, Bor-Sheng Ko, MD PhD, Wen-Chien Chou, MD PhD, Yun-Chu Lin, MD, Chieh-Lung Cheng, MD, Li-Chun Lu, MD PhD, Sung-Hsin Kuo, MD PhD, Ruey-Long Hong, MD PhD, Tai-Chung Huang, MD PhD, Ming Yao, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138481

Published: 2020

NARROW

Validation and Retraining of the Stellae-123 Gene Expression Signature Improved Risk Stratification in Taiwanese Acute Myeloid Leukemia Patients

Genomic Characterization of Acute Myeloid Leukemia with Aberrations of Chromosome 7: A Multinational Cohort of 523 Patients

FLT3 Testing and Clonal Evolution in Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study in Taiwan

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Prognostic and Therapeutic Implications of TP53 expression in Chronic Myelomonocytic Leukaemia: Results of a Multicentre Study

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification

A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia

Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation

Effect of Mutation Allele Frequency on the Risk Stratification of Myelodysplastic Syndrome Patients

Conditional Knock-out of Phf6 Decreases CD44 Expression on Naïve CD4 + T Cells and Skews the Differentiation Toward Regulatory T Cells in Mice

Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3 mut+ AML ineligible for intensive chemotherapy

Phase 3, Open-Label, Randomized Study of Gilteritinib and Azacitidine Vs Azacitidine for Newly Diagnosed FLT3 -Mutated Acute Myeloid Leukemia in Patients Ineligible for Intensive Induction Chemotherapy

RUNX1 Expression Can be Complementary to RUNX1 Mutation in MDS Prognostication

Metabolic Profiling Reveals Cellular Reprogramming of Acute Myeloid Leukemia By Omipalisib through Serine Synthesis Pathway

Epidemiology of Light-Chain Amyloidosis: A Population-Based Cohort Study in Taiwan

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only